Articles written by: Joseph Taylor

On February, 14 Carlisle Companies Incorporated (CSL) Analysts See $1.23 EPS

On February, 14 Carlisle Companies Incorporated (CSL) Analysts See $1.23 EPS

During Q3 2018 the big money sentiment decreased to 0.72. That’s change of 0.12, from 2018Q2’s 0.84. 22 investors sold all, 129 reduced holdings as Carlisle Companies Incorporated ratio is negative. 60 rose holdings while 49 funds amassed holdings. Funds hold 49.36 million shares thus 3.44% less from 2018Q2’s 51.12 […]

Cardinal Health, Inc. (CAH) EPS Estimated At $1.09 as of February, 14

Cardinal Health, Inc. (CAH) EPS Estimated At $1.09 as of February, 14

During Q3 2018 the big money sentiment increased to 0.99. That’s change of 0.03, from 2018Q2’s 0.96. 51 investors sold all, 195 reduced holdings as Cardinal Health, Inc. ratio increased. 176 rose stakes while 68 funds acquired stakes. Funds hold 258.08 million shares thus 2.70% less from 2018Q2’s 265.24 million […]

Analysts See $0.80 EPS for Waste Connections, Inc. (WCN) on February, 13

Investors wait Waste Connections, Inc. (TSE:WCN)’s quarterly earnings on February, 13 after the close., as reported by RTT. The earnings per share diference is $0.14 or 21.21 % up from last years number. Previous year: $0.66; Analysts forcast: $0.80. In case of $0.80 earnings per share T_WCN’s profit could reach […]

EPS for Birchcliff Energy Ltd. (BIR) Expected At $0.13 as of February, 13

On February, 13. Investors wait Birchcliff Energy Ltd. (TSE:BIR) to reveal its quarterly earnings, according to Faxor. Analysts predict 44.44 % diference or $0.13 from the $0.09 EPS from 2018. If the current EPS of $0.13 is accurate, T_BIR’s profit could be $34.57M. Analysts at Wall Street see Birchcliff Energy […]

On February, 13 The EPS for Intercept Pharmaceuticals, Inc. (ICPT) Expected At $-2.42

On February, 13 The EPS for Intercept Pharmaceuticals, Inc. (ICPT) Expected At $-2.42

Big Money Sentiment decreased to 1.25 in Q3 2018. It has change of 0.02, from 2018Q2’s 1.27. The ratio worsened due to Intercept Pharmaceuticals, Inc. positioning: 17 sold and 44 reduced. 37 funds amassed positions and 39 increased positions. Investors holded 19.65 million in 2018Q2 but now own 18.21 million […]